Balloon Catheter

This channel includes news and new technology innovations for angioplasty balloon catheters (PTA). These are used in arteries with atherosclerotic lesions to compress the plaque expand the artery lumen to reopen occluded or heavily stenosed atherosclerotic lesions. Balloons are often used in combination with a stent to prop the treated vessel segment open. In addition to plain old balloon angioplasty (POBA), this section includes news about drug-coated balloon (DCB), valvuloplasty balloons and specialty cutting balloon.

Videos | Balloon Catheter | October 30, 2015
Todd Brinton, M.D., clinical associate professor and consulting associate professor of bioengineering at Stanford...
ISAR-DESIRE 4 trial, TCT 2015, drug-coated balloon, DCB, scoring balloon, SCB, drug-eluting stent restenosis

Image courtesy of Medtronic

Feature | Drug-Eluting Balloons | October 22, 2015
October 22, 2015 — Results from the ISAR-DESIRE 4 trial indicate that use of a scoring balloon plus a paclitaxel-coated...
IN.PACT SFA study, TCT 2015, drug-coated balloons, PTA, SFA disease, superficial femoral artery

Image courtesy of Medtronic

Feature | Peripheral Artery Disease (PAD) | October 18, 2015
October 18, 2015 — Two-year results from the IN.PACT SFA study found the use of a drug-coated balloon was superior to...
Lutonix Global Real-World Registry results, TCT 2015, Lutonix 035 DCB, peripheral arterial disease, PAD

Image courtesy of C.R. Bard

News | Drug-Eluting Balloons | October 15, 2015
October 15, 2015 — C. R. Bard Inc. announced the presentation of the 12-month results from the Lutonix Global Real-...
News | Cath Lab | October 09, 2015
October 9, 2015 — Cardinal Health is launching its expanded portfolio in the cardiovascular space including the latest...
Intact Vascular, TOBA II study, Tack Endovascular System

Image courtesy of Intact Vascular
 

News | Peripheral Artery Disease (PAD) | October 01, 2015
October 1, 2015 — Intact Vascular Inc. announced the U.S. Food and Drug Administration has granted conditional approval...
News | Cath Lab | August 26, 2015
August 26, 2014 — The Cardiovascular Research Foundation (CRF) announced the late-breaking trials and first report...
C.R. Bard, LEVANT 2 results, Lutonix 035 DCB, drug coated balloon, PTA
Feature | Drug-Eluting Balloons | July 08, 2015
July 8, 2015 - C.R. Bard Inc. announced the publication of results from the LEVANT 2 study in the June 24, 2015, online...
Lutonix DCB, CMS, reimbursement, pass-through payment, outpatient use
News | Drug-Eluting Balloons | June 11, 2015
June 11, 2015 - C.R. Bard Inc. announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has improved...
Medtronic, Euphora SC balloon, CE Mark, Europe, Richard Edwards
News | June 05, 2015
June 5, 2015 - Medtronic announced the launch of the Euphora semicompliant balloon dilatation catheter in countries...
Shockwave Medical, Lithoplasty, $40 million, funding, Sofinnova, Venrock
Feature | May 27, 2015
May 27, 2015 — Shockwave Medical announced $40 million in funding, co-led by returning investor Sofinnova Partners and...
IN.PACT Admiral, Global Study, DEB SFA-LONG, long peripheral lesions, EuroPCR
News | May 22, 2015
May 22, 2015 — New clinical data from two different studies show the IN.PACT Admiral drug-coated balloon from Medtronic...
Medtronic, Euphora, SC, semicompliant balloon dilatation catheter, FDA, U.S.
Technology | May 08, 2015
May 8, 2015 — Medtronic plc announced U.S. Food and Drug Administration (FDA) 510(k) clearance and U.S. launch of the...
Stellarex, Spectranetics, investment, BTK, peripheral artery disease
News | May 06, 2015
May 6, 2015 — The Spectranetics Corporation announced it is accelerating investments in the Stellarex drug-coated...